Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Oct 25;8(3):183-92.
doi: 10.1038/nrendo.2011.158.

Resistance to type 2 diabetes mellitus: a matter of hormesis?

Affiliations
Review

Resistance to type 2 diabetes mellitus: a matter of hormesis?

Hubert Kolb et al. Nat Rev Endocrinol. .

Abstract

Type 2 diabetes mellitus is characterized by subclinical systemic inflammation and impaired regulation of blood glucose levels. Interestingly, impairment of glycemic control occurs despite substantial insulin secretion early in the course of this disease. Dysfunction of several organs (including pancreatic islets, liver, skeletal muscle, adipose tissue, gut, hypothalamus and the immune system) has been implicated in the pathogenesis of type 2 diabetes mellitus. However, diabetes-promoting lifestyle factors do not inevitably cause disease in all persons exposed. Hence, defense mechanisms must exist that can keep the detrimental influence of these risk factors at bay. Hormesis describes the phenomenon that exposure to a mild stressor confers resistance to subsequent, otherwise harmful, conditions of increased stress. This Review discusses the emerging concept that the effectiveness of an adaptive (hormetic) response to detrimental lifestyle factors determines the extent of protection from progression to type 2 diabetes mellitus. Further analysis of these protective hormetic responses at the molecular level should help to identify novel targets for preventive or therapeutic intervention in patients at risk of developing type 2 diabetes mellitus or those with overt disease.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Scand J Med Sci Sports. 2011 Jun;21(3):420-30 - PubMed
    1. Diabetes. 2010 Aug;59(8):1899-905 - PubMed
    1. Diabetes. 2008 Nov;57(11):3090-8 - PubMed
    1. Science. 2004 Oct 15;306(5695):457-61 - PubMed
    1. Circulation. 2002 Oct 15;106(16):2067-72 - PubMed

Publication types